Prevalence and Prognosis of Cardiac Amiloidosis in Turkey

Recruiting

• Conditions: Cardiac Amyloidosis

• Registration Number: NCT04915235
• Lead Sponsor: Turkish Society of Cardiology

Brief Summary

Patients with left ventricular hypertrophy are further examined according to an algorithm to check if they have a cardiac amyloidosis

Detailed Description

Not available

Study Timeline

• Study Start: 2020-09-18
• Status Verified: 2021-05
• Study First Submitted: 2021-05-31
• Study First Submitted QC: 2021-05-31
• Last Update Submitted: 2021-05-31
• Study First Posted: 2021-06-07
• Last Update Posted: 2021-06-07
• Primary Completion: 2025-12-31
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 2087

Inclusion Criteria

• Patients with left ventricular hypertrophy without left ventricular pressure or volume (IVS≥13mm)
• Patients with left ventricular hypertrophy and hypertension or aortic stenosis without left ventricular pressure or volume (IVS>15mm)

Exclusion Criteria

• Patients with left ventricular pressure or volume except the ones with aortic stenosis and arterial hypertension
• Patients with sigmoid septum and their hypertrophy limited in sigmoid area
• Patients with highly probable sarcometric hypertrophy cardiomyopathy confirmed with LV morhpology and genetic testing

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cardiac Amyloidosis	Upon screening	Patients with left ventricular hypertrophy and Cardiac Amyloidosis

Trial Locations

Locations (1)

Dokuz Eylul University Faculty of Medicine; 🇹🇷 Izmir, Turkey